Acute promyelocytic leukemia (APL), which accounts for about 10% of acute myeloid leukemias, is characterized by the presence of the specific chromosomal translocation t(15;17)(q22;q21). This translocation produces the fusion of the retinoic acid receptor a (RARA) gene on chromosome 17 with the promyelocytic leukemia (PML) gene. 1 The breakpoints in the RARA gene are located within 15 kb of intron 2. Three regions of the PML locus are involved in the translocation breakpoints: bcr1 in intron 6, bcr3 in intron 3 and bcr2 in exon 6. Patients with short bcr2 transcripts as a consequence of exon 6 PML deletions are referred as V-form PML-RARa. [2] [3] [4] In this work, we report an unusually large exon 6 PML deletion (161 bp) associated with a short intron capture (5 bp), giving rise to a net 156 bp deletion (52 amino acids). The outcome was good.
A 33-year-old Honduran woman who had been living in Catalonia for 2 years was admitted to the Hospital Josep Trueta at Girona in September 2006 with marked asthenia and easy bruising on both legs. Blood analysis showed hemoglobin of 64 g/l, mean corpuscular volume (VCM) 82.9 fl, hematocrit 18%, leukocytes 2.6 Â 10 9 /l (neutrophils: 11%; lymphocytes: 36%; monocytes: 9%; blasts: 43% with coarse granules and Auer rods) and platelets, 60 Â 10 9 /l. The international normalized ratio of prothrombin (INR) time was 1.84 and fibrinogen 126 mg/dl. A bone marrow aspirate performed at admission disclosed a typical picture of acute promyelocytic leukemia and the karyotype was 46, XX, t(15;17)(q22;q21.1).
Molecular findings revealed a short type bcr 2 transcript (V-form) with a net 156 bp deletion ( Figure 1 group. The patient reached a complete clinical and molecular remission and is currently in CR 7, months after diagnosis.
Slack et al. 2 reported the clinical characteristics of V-form APL and demonstrated the aggressive behavior of some of these cases. V-form APL is more common in pediatric patients. Several studies have attempted to correlate the type of PML-RARa transcript with clinico-biologic features at diagnosis or with treatment response and outcome. Blasts from V-form patients with large PML exon 6 truncations have been found to be relatively resistant to all-trans retinoic acid (ATRA) in vitro. Those cases of APL in which the V-type transcript showed an increased affinity to the nuclear corepressor protein SMRT had an aggressive course. This recruitment would be mediated by an intronic spacer sequence flanked by gt splice donor sites. 3, 4 Given that the patient under discussion had an unusually large deletion, we performed direct sequencing to rule out a large intron capture produced by a mechanism of illegitimate recombination. Furthermore, we were interested in learning how this unusual transcript could affect the currently used minimal residual disease studies using real-time PCR. 5 The short intron sequence and the good outcome under ATRA were in line with previous reports. 3 BIOMED protocols were suitable to detect and monitor this patient. 6, 7 Further cases of V-form PMLRARa rearrangement need to be analyzed to identify those acute promyelocytic cases that require alternative therapies to ATRA. 
